Clinical Trial Update: SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLC [Phase 2]

View source ↗

Summary

This document details a Phase 2 clinical trial of SHR-A1811 plus AK112 in HER2-altered advanced/metastatic non-small cell lung cancer, which is currently not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AK112
• SHR-A1811

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING